![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 75.00 | 73.00 | 77.00 | 75.00 | 75.00 | 75.00 | 22,023 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -6.93 | 49.49M |
RNS Number:0172X Celsis International PLC 29 March 2004 CELSIS INTERNATIONAL PLC Preliminary Results Announcement Date Celsis International plc, a leading international manufacturer of rapid diagnostic systems for the world's pharmaceutical, personal care, dairy and beverage industries and a leading US supplier of cGMP analytical services for the pharmaceutical industry, will announce its Preliminary Results for the year ended 31 March 2004, on Thursday 27 May 2004. There will be a presentation to analysts on the day at 11.00am, held at College Hill, 78 Cannon Street, London, EC4N 6HH. 29 March 2004 Enquiries: Celsis International plc Tel: 01638 600 151 Jay LeCoque, Chief Executive Officer Jenny Parsons, Corporate Communications College Hill Tel: 020 7457 2020 Nicholas Nelson Corinna Dorward This information is provided by RNS The company news service from the London Stock Exchange END NORZGGZFNVGGDZM
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions